Navigation Links
DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC

. In extremely minute quantities, botulinum toxin can be used therapeutically, as for the cosmetic use of Botox®, a commercial preparation of serotype A botulinum toxin, but the effects of the neurotoxin are extremely long lasting and paralytic at higher than therapeutic doses.

About Botulinum Toxin Vaccines

Vaccination is considered the best option to prevent neurological effects of toxin exposure. Because of the rarity of the natural disease, a vaccine would not be used in mass population immunization programs unless they were actually used or a significant threat. In that event, the vaccine would have to be made available for widespread dissemination for rapid and convenient vaccination of a large population. The only vaccine available is an experimental vaccine based on inactivation of a mixture of serotypes of the natural toxins that is given by injection, is not licensed by the FDA and cannot be used for widespread immunization. New multivalent vaccines based on non-toxic subunits are being developed, including BT-VACC™.

About DOR BioPharma, Inc.

DOR BioPharma, Inc. is a biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal ("GI") diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally acting corticosteroid being developed for the treatment of GI graft-versus-host disease ("GVHD"), a common and potentially life-threatening complication of bone marrow transplantation. DOR has filed an NDA with the FDA for the treatment of GI GVHD, and has received a PDUFA date of July 21, 2007. An MAA with the EMEA for orBec® has also been filed and validated. orBec® may also have application in treating other gastrointestinal disorders characterized by severe inflammation. DOR has also recently initiated a clinical development program with its Lipid Polymer Micelle
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:5/5/2015)... , May 5, 2015   Temptime Corporation ... the health care industry, announced today that its board ... Hooff to chief executive officer.  Mr. Van ... Temptime since 2011. "Renaat deeply values Temptime,s ... outstanding job of expanding Temptime,s products and services to ...
(Date:5/5/2015)... 2015  Trovagene, Inc. (NASDAQ:  TROV), a developer ... results for the three months ended March 31, ... we presented favorable clinical results at ASCO GI, ... our Precision Cancer Monitoring platform,s ability to detect ... lung cancers," said Antonius Schuh, Ph.D., chief executive ...
(Date:5/5/2015)... /CNW Telbec/ - Ergoresearch Ltd (TSXV: ERG) ... known under the « Équilibre, orthèses et biomécanique» ... previously announced on April 23, 2015 regarding the acquisition ... Orthoconcept (2008) inc.   The purchase price ... ERG) to the vending shareholder, namely 9211-5096 Québec inc.. ...
Breaking Medicine Technology:Temptime President Renaat Van den Hooff Promoted to CEO 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3
(Date:5/6/2015)... CA (PRWEB) May 06, 2015 ... in an upcoming episode of Innovations with Ed ... 2015. Dates and show times TBA. , This ... dedicated to advancing tissue-based diagnostics. Audiences will learn ... IHC). Innovations will go behind the scenes to ...
(Date:5/6/2015)... 2015 When it comes to advice ... reputable and respected than those of a physician. It ... physician lose more weight than those who received no ... by the University of Georgia and published in the ... that patients advised by their physicians dropped more pounds, ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Healthcare marketing ... award and a silver award in the 2015 Aster ... care campaign and Ellis Medicine’s maternity campaign, respectively. The ... by healthcare organizations and marketing agencies. , The ... the service line — other/misc. category and hospital 150-200 ...
(Date:5/6/2015)... More and more people are finding success ... Flatt, personal trainer and nutritionist. This particular diet program has ... just three weeks or 21 days. , According to author ... and found to work on all types of people, regardless ... lose between 12 and 23 pounds using the diet, although ...
(Date:5/5/2015)... 06, 2015 Social Media Regulatory Affairs ... Media Your Most Powerful Marketing Tool and Get the ... http://www.fdanews.com/SocialMedia , Social media … Is it ... media’s reach. Patients are using it — learning about ... what they’ve discovered. , But, it can become a ...
Breaking Medicine News(10 mins):Health News:Novodiax to Be Featured in Upcoming Episode of Innovations TV Series 2Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 2Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 3Health News:Smith & Jones Wins in 2015 Aster Awards for Healthcare Marketing 2Health News:Brian Flatt Announces The 3 Week Diet - A Scientifically Proven Diet Plan 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 4
... ... problems, Sam’s Club is hosting free health screenings in more than 400 of its locations ... ... help its members and community residents detect a range of preventable health problems, Sam’s Club ...
... researcher is developing a novel therapy for Alzheimer,s disease ... builds up in the brain of an Alzheimer,s patientan ... and higher in effectiveness than current therapies. ... of Chemical, Biological and Mechanical Engineering, recently received a ...
... The Fogarty International Center of the National Institutes of ... an international AIDS training and research program based at ... countries most affected by the HIV/AIDS epidemic. The ... University and Tufts University since 1993 is part ...
... Donations ... ... -- Thousands of Haitian women and young girls living in temporary camps will sleep safer ... Idol viewers. More than $250,000 was raised for the United Nations Foundation ...
... ... acclaimed Anti-Phishing Phil online training game with updated graphics and content, as well as ... , ... 2010 -- Today Wombat Security Technologies announced it has released version 2.0 of its ...
... In 20 years, approximately 72 million older adults ... current number, according to the U.S. Administration on Aging. ... health care workers needed to provide elder care. As ... of Missouri researchers is refining electronic health record (EHR) ...
Cached Medicine News:Health News:Sam's Club Hosts Health Screenings July 10 2Health News:OU researcher developing novel therapy for Alzheimer's disease 2Health News:International AIDS training and research program awarded $3.6 million from NIH 2Health News:Haiti: United Nations Gets a Helping Hand from American Idol Viewers 2Health News:Haiti: United Nations Gets a Helping Hand from American Idol Viewers 3Health News:New Release of Wombat Security Technologies' Cyber Security Training Game: Anti-Phishing Phil 2Health News:Electronic health records prime clinicians to provide progressive care to older adults 2
... This model offers all of the ... 2 densitometer with the additional feature ... a small imaging scanner for importing ... immunofixation results or images. This additional ...
Inquire...
... Sebia's Normal and Hypergamma Controls ... on either agarose gels or ... system. Our unique control manufacturing ... as the other serum components, ...
... gel electrophoresis system is designed to ... in classic electrophoresis and immunofixation testing. ... phases of electrophoresis from sample ... staining, destaining and drying. The walkaway ...
Medicine Products: